7,8-Dihydroxyflavone Attenuates Alcohol-Related Behavior in Rat Models of Alcohol Consumption via TrkB in the Ventral Tegmental Area
Open Access
- 19 May 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 14, 467
Abstract
Alcohol use disorder (AUD) is a ubiquitous substance use disorder in the world, of which neural mechanisms remain unclear. Alcohol consumption induces neuro-adaptations in the dopaminergic system originating from the ventral tegmental area (VTA), an important brain region for the reward function in AUD. Endogenous brain-derived neurotrophic factor (BDNF)-TrkB implicated in the development of neuroplasticity, including long-term potentiation of GABAergic synapses (LTPGABA). We previously found that ethanol blocks LTPGABA in the VTA, either in vivo or in vitro. 7,8-dihydroflavone (7,8-DHF), a BDNF-mimicking small compound, was recently found to penetrate the blood–brain barrier to mimic the biological role of BDNF-TrkB. In this study, we demonstrate that repeated ethanol consumption (including intermittent and continuous ethanol exposure) results in low expression of BDNF in rat VTA. The amount of ethanol intake enhances significantly in rats with intermittent ethanol exposure after 72 h abstinence. Withdrawal signs emerge in rats with continuous ethanol exposure within 3 days after abstinence. Using behavioral tests, intraperitoneal injection of 7,8-DHF can reduce excessive ethanol consumption and preference as well as withdrawal signs in rats with repeated ethanol exposure. Interestingly, microinjection of K252a, an antagonist of TrkB, into the VTA blocks the effects of 7,8-DHF on ethanol-related behaviors. Furthermore, direct microinjection of BDNF into the VTA mimics the effect of 7,8-DHF on ethanol related behaviors. Taken together, 7,8-DHF attenuates alcohol-related behaviors in rats undergoing alcohol consumption via TrkB in the VTA. Our findings suggest BDNF-TrkB in VTA is a part of regulating signals for opposing neural adaptations in AUD, and 7,8-DHF may serve as a potential candidate for treating alcoholism.Keywords
Funding Information
- National Natural Science Foundation of China (81871041, 81371463)
- National Basic Research Program of China (2018YFC1314404)
- Natural Science Foundation of Heilongjiang Province (H2017076)
This publication has 63 references indexed in Scilit:
- Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinkingProceedings of the National Academy of Sciences, 2012
- Microinjection of Glycine into the Ventral Tegmental Area Selectively Decreases Ethanol ConsumptionThe Journal of Pharmacology and Experimental Therapeutics, 2012
- GABAergic Actions Mediate Opposite Ethanol Effects on Dopaminergic Neurons in the Anterior and Posterior Ventral Tegmental AreaThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNFPharmacology Biochemistry and Behavior, 2011
- 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2011
- Elevated BDNF after Cocaine Withdrawal Facilitates LTP in Medial Prefrontal Cortex by Suppressing GABA InhibitionNeuron, 2010
- Ethanol Blocks Long-Term Potentiation of GABAergic Synapses in the Ventral Tegmental Area Involving μ-Opioid ReceptorsNeuropsychopharmacology, 2010
- A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavoneProceedings of the National Academy of Sciences, 2010
- Spontaneous glutamatergic activity induces a BDNF‐dependent potentiation of GABAergic synapses in the newborn rat hippocampusThe Journal of Physiology, 2008
- Ethanol–BDNF interactions: Still more questions than answersPharmacology & Therapeutics, 2008